Cytoskeletal Organization and Rb Tumor Suppressor Gene by Yi-Jang Lee et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
8 
Cytoskeletal Organization and  
Rb Tumor Suppressor Gene 
Yi-Jang Lee1,*, Pei-Hsun Chiang1 and Peter C. Keng2 
1Department of Biomedical Imaging and Radiological Sciences,  
National Yang-Ming University, Taipei 
2Cancer Center, School of Medicine and Dentistry,  
University of Rochester, Rochester, NY 
1Taiwan, R.O.C. 
2USA 
1. Introduction 
Cell cycle progression is dependent on a series of molecular regulation after cells are 
stimulated by growth factors. Growth factors bind to corresponding surface receptors and 
relay the signals through protein phosphorylation to trigger gene expression. 
Phosphorylation of retinoblastoma protein (Rb) is to release E2F family of transcription 
factors for DNA replication. In adherent cells, the actin filament plays an important role for 
anchorage, locomotion, morphological maintenance, and cell division (1). These mechanical 
characteristics influence cell cycle progression, and mediate cells responding to extracellular 
stimulations. The cyclin-dependent kinases (CDKs) are responsible for cell cycle transition 
through different phases. For G1 phase progression, the G1 cyclins associated CDKs can 
phosphorylate and inactivate Rb. Because the phosphorylation sites of Rb are multiple, they 
become a family of checkpoint to prevent release of E2F transcription factor under a stress 
condition, such as DNA damage. In addition, the CDKs activity and Rb phosphorylation are 
ablated by the family of CDK inhibitors (CKIs), including INK4 and CIP/KIP family 
proteins (2). The underlying mechanisms by which the intact actin filaments regulated cell 
cycle progression have been reviewed in literatures, although the pathways are diverse from 
different research results. However, it appears that Rb activity is commonly affected by 
destabilizing the actin cytoskeleton. Therefore, it is believed that growth factor stimulated 
actin cytoskeletal organization can regulate Rb activity for G1 phase progression and DNA 
replication.  
Although actin cytoskeletal organization affects Rb activity, the cell cycle regulatory 
components have been recently reported to influence actin organization and cell motility (3). 
It is largely associated with CIP/KIP family proteins when they relocate to cytoplasm from 
nucleus. They inhibit Rho small GTPase family protein for actin architectures formation. 
Interestingly, Rb may regulate CIP/KIP protein expression through E2F transcriptional 
activity (4), and this observation implies that an autoregulatory mechanism may exist 
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between actin cytoskeletal organization and Rb for regulating cell growth and cell cycle 
progression. Investigation of these biological events would contribute to cancer research and 
therapeutic design for cancer treatment or prevention.  
2. Actin cytoskeletal reorganization during cell cycle progression 
The cytoskeleton consists of three different types of cytosolic fibers that include actin 
filaments (also named microfilaments), intermediate filaments, and microtubule. Of the 
three types of fibers, actin filaments are primarily responsible for cell mobility, anchorage, 
and shape maintenance. Actin filaments are formed by polymerizing the ATP-bound actin 
subunits, so called G-actin, through a energy-required dynamic process. Actin filaments can 
be organized into different types of actin cytoskeletons including stress fibers, lamellipodia, 
and filapodia distributed in different regions of cells for specific functions. It is well-known 
that Rho small GTPase family proteins are responsible for actin organization. Organization 
of actin filaments is associated with cell growth depending on cell adhesion and mitogenic 
stimulation (5).  
Accumulated evidences have supported the essence of actin cytoskeleton for cell division 
and proliferation. In fibroblasts, addition of growth factors or other mitogenic stimulation 
can promote the generation and reorganization of actin cytoskeleton through the small G 
proteins, including Rac, Cdc42, and Rho (6). Rac and Cdc42 are important for formation of 
lamellipodia and filapodia at the leading edges of cells, while Rho is responsible for 
formation of stress fibers. Actin filaments are organized into different types of actin 
structures to support cell growth after mitogenic stimulation. Moreover, actin filaments are 
organized at the focal contacts, in which integrins and other cytoskeletal proteins are 
present for cell attachment (7). Formation of focal contacts is important for activating a 
series of signaling pathways such as phosphatidylinositol 3-kinase (PI3-kinase) and 
mitogen-activated protein kinase (MAPK) pathways (8, 9). Actin filaments are important for 
transducing signals from extracellular matrix into cells for growth. Inhibition of actin 
filaments after cell attachment leads to blockage of signaling pathways and subsequent 
growth arrest (10-12). Actin filaments and cell adhesion are also important for cell cycle 
progression (13). It has been reported that cells with disorganized actin architecture are 
unable to initiate DNA synthesis (14). Therefore, it appears that actin filaments are 
important for cell growth and normal cell cycle progression.  
Actin filaments are also important for cell division at the telophase during mitosis. Myosin 
II, one of the actin-binding proteins that moves on actin filaments, binds to actin filaments to 
form the contractile ring at the middle part of the dividing cell and to pull the plasma 
membrane inward to form a cleavage furrow (15). Disruption of actin filaments at 
cytokinesis can lead to failure of division and growth arrest. Collectively, organization of 
actin filaments is associated with cell growth in both cell signaling and structural aspects.  
The distribution of actin cytoskeleton in different phase of the cell cycle has been studied 
more than two decades. Mitotic phase is the most obvious dynamic stage that microtubule 
and actin cytoskeletal reorganization can be detected. It is broadly accepted that 
microtubule formed spindles are critical for chromosomal segregation during mitosis. These 
fine-tune mitotic spindles are then required for driving the cytokinesis, a cell dividing step 
ablated by the actin filaments and myosin II sliding machine, for separation of the daughter 
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cells (16-18). On the other hand, the role of actin filaments on spindle assembly and 
positioning are less studied. In fact, the theories of actin cytoskeletal formation in mitotic 
phase are debated. Investigation of actin cytoskeletal organization in higher plant cells such 
as meristematic root-tip cells of Allium and staminal hairs have shown that the cytoplasmic 
actin filaments cannot be detected until the entry of cytokinesis (19-21). The last moment for 
visualizing the actin filaments right before cells entering the mitosis is likely to be the 
preprophase (22). Reorganization of actin filaments is found at the contractile ring 
accompanied by the formation of cleavage furrow, while disruption of actin reorganization 
using cytochalasin leads to mitotic arrest and aneuploid formation (23-25). However, 
accumulated literatures also demonstrate that actin filaments dramatically influence the 
mitotic spindle positioning and assembly not only in plant cells but also in fruitflies, C. 
elegans zygotes, Xenopus embryos and mouse oocytes during syncytial divisions (26-33). 
The role of actin filaments is to regulate astral microtubule growth and spindle migration by 
reorganizing in the cortical region (34). Disruption of cortical actin filaments leads to 
misorientation of spindles and cell cycle arrest (35). Also, myosin-10 and actin filaments play 
cooperative but distinct functions on the mitotic spindle formation, proper spindle 
anchoring, spindle pole integrity, spindle length control, and mitotic progression. We 
looked into the different stages of anaphase and showed that actin cytoskeletal organization 
also changed and orchestrated with microtubule for cell division (Figure 1). Taken together, 
it has become clear that the actin cytoskeleton can interact with microtubule organized 
spindle fibers for mitotic progression and cell divisions.  
Although actin cytoskeletal organization has been well-studied in the mitotic phase, the 
shape variations of actin cytoskeleton in the interphase remain unclear. The interphase of 
cell cycle includes G1, S and G2 phase. However, the actin organization in each phase is not 
well described in the literature. Yu et al. investigated the actin dynamics during the cell 
cycle in suspension-cultured tobacco BY-2 (Nicotiana tabacum L. cv Bright Yellow) cells using 
a green fluorescent protein (GFP) fused mouse Talin (mTalin) gene, which can indicate the 
positions of actin cytoskeleton in the plant cells. Their results clearly indicate the positions of 
cortical actin cytoskeletal networks in the interphase, and they are altered organized and 
even disappeared before cells enter mitosis and pre-prophase. Instead, the actin 
cytoskeletons relocalize to the future equatorial plane and centrally located nucleus and 
vesicles. Therefore, it is believed that actin cytoskeletal organization should vary in different 
stages of interphase. We have synchronized human non-small lung cancer H1299 cells at 
G1/S phase boundary using the double thymidine block protocol, and collected cells at 
different time intervals for staining of actin cytoskeletal organization using the fluorescine-
conjugated phalloidin. As shown in figure 2, the actin networks concentrated around 
nucleus during S phase and pre-prophase (Figure 2). The cortical actin cytoskeleton formed 
in mitotic phase are consistent with the results reported previously (36), while the actin 
assemblies are also visualized between segregating chromosomes from the early anaphase 
to telophase. Actins are organized to visible stress fibers in the G1 phase and mediate 
morphological maintenance and spreading. The actin architectures are also continuously 
changed in the G1 phase progression. Although the underlying mechanisms remain to be 
studied for the association between cell cycle and actin cytoskeletal organization, we have 
found that the level of actin depolymerizing factor cofilin-1, a protein required for actin 
dynamics and reorganization, is also changed in G1 to S phase progression (unpublished 
data). The activity of cofilin-1 has been reported to be essential for G2/M phase progression  
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Fig. 1. Coordination of actin filaments and microtubules for mitotic cells passing from 
anaphase to telophase and cytokinesis in human non-small lung cancer H1299 cells. The 
conventional fiber-like structures were not visualized, while the cortical actin cytoskeletons 
are formed. F-actin was stained by fluorescine-conjugated phalloidin; microtubule was 
stained by anti-tubulin antibody; DAPI (4',6-diamidino-2-phenylindole) was used for 
nuclear staining. 
(37, 38). We have also found that over-expression of cofilin-1 can inhibit G1 phase 
progression (39, 40). Thus, cofilin-1 may regulate actin cytoskeleton not only in the G2/M 
phase but also in G1 and S phase progression.  
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Fig. 2. The change of actin architectures during cell cycle progression. H1299 cells were 
synchronized in S phase using double thymidine block. (A) The cell cycle progression from 
S phase to next G1/S boundary was demonstrated by DNA histogram and the expression of 
cyclin B; (B) cells were collected at different stage of the cell cycle and stained for actin 
cytoskeleton using fluorescine-conjugated phalloidin.  
3. Molecular events for cell cycle progression in mammalian cells 
In eucaryotes, cell proliferation is partially dependent on cell cycle progression. Cyclin and 
cyclin-dependent kinases (CDK) are required for progression through gap phases (G1 and 
G2), DNA replication (S), and chromosome segregation (M) phases of the cell cycle. Protein 
complexes of cyclin and cyclin-dependent kinase (CDK) can phosphorylate specific 
downstream substrates, including retinoblastoma tumor suppressor protein (Rb) or 
anaphase-promoting complex (APC), for G1/S or M phase transition, respectively (41, 42). 
The activity of cyclin/CDK for G1 phase progression is regulated by CDK inhibitors, which 
can bind to cyclin/CDK and inhibit its activity. On the other hand, the CDK inhibitors 
p21CIP1 and p27KIP1 are indispensible for cyclin/CDK activity, suggesting that a 
stoichiometric balance is existed among cyclins, CDKs and CDK inhibitors (2, 43). Also, cell 
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cycle progression can be inhibited by genotoxic stresses, such as ionizing radiation and 
some chemotherapeutic agents. In normal cells, activation of tumor suppressor gene p53 is 
usually involved in this type of response. 
Different types of cyclins (A, B, C, D, and E) and CDKs (1, 2, 3, 4, and 6) are responsible for 
the progression of cells into different stages of cell cycle. Cyclin A binds to CDK2 for S-G2 
phase progression, while cyclin B binds to CDK1 for entry into M phase. The cyclin 
C/CDK3 complex can promote Rb-dependent G0 phase exit (44). Cyclin D binds to CDK4/6 
and cyclin E binds to CDK2 for G1 phase progression, although the latter is primarily 
responsible for late G1 phase or G1-S phase transition. Cyclin D consists of three closely 
related D-type cyclins, named Cyclin D1, D2, and D3. Expression of different types of cyclin 
D for G1 phase progression is likely to be tissue-specific (45). For G1 to S phase progression, 
Rb is phosphorylated by cyclin D-CDK4/6 and cyclin E-CDK2 to release E2F1, an important 
transcription factor belonging to the E2F protein family for entry into S phase (46-49). The 
gene targets of E2F1 are versatile and involved in DNA synthesis and G1/S progression, 
including DNA polymerase alpha, cyclin E, and E2F1 itself (50, 51).  
Rb is a phosphoprotein containing sixteen serine/theronine sites that can be recognized by 
cyclin/CDKs. Mutations of nine of these consensus phosphorylation sites, including seven 
sites at the C-terminal and two sites at the insert region of Rb, are sufficient to constitutively 
active Rb and block DNA replication (52-54). Also, mutations of this phosphorylation site 
can cause different cell cycle and apoptotic effects in Rat-16 cells exposed to various stimuli, 
such as tumor necrosis factor, doxorubicin or staurosporine (55). In addition, Rb may 
mediate DNA damage response (DDR). It has been reported that Rb-deficient cells are 
incapable of cell cycle arrest and are hypersensitive to apoptosis following DNA damage 
(56). This result suggests that Rb may protect cells from DNA damage-induced apoptosis. 
However, phosphorylation of Rb via p38 kinase or ASK1 can inactivate Rb and promote 
apoptosis (57-60). These apoptosis-associated phosphorylation sites are independent of 
those targeted by cyclin/CDKs on Rb (60).  
Although Rb phosphorylation is mainly mediated by D cyclin-CDK4/6 and E cyclin-CDK2 
in the G1 phase, high dose of ionizing radiation induced DNA damage can permanently 
cause G2 phase arrest accompanied by a gradual accumulated hypophosphorylated Rb (61). 
Because cyclin B-CDK1 is responsible for G2 phase progression, reduced CDK1 activity is 
likely to be the cause of hypophosphorylated Rb in G2 phase. Interestingly, CDK1 has been 
reported to be the only essential cell cycle CDK because it can bind to all cyclins and control 
the Rb phosphorylation (62). Although it is difficult to demonstrate that cyclin B-CDK1 can 
mediate Rb phosphorylation in the G1 phase, it is plausible that Rb phosphorylation is 
ablated by CDK1 in the G2 phase. Actually, Rb phosphorylation is accompanied by the 
expression of cyclin B during mitosis. That is, Rb phosphorylation and cyclin B are 
concomitantly decreased from the prophase to telophase of mitosis (63). Besides, it has been 
reported that phosphorylation of amino terminus of Rb protein is mediated by a G2/M 
phase specific cell cycle-regulated Rb/histone H1 kinase (RbK), a kinase exhibits different 
enzymatic activity compared to CDK1 and CDK2 (64, 65). RbK may play a role in G2 
checkpoint by controlling the Rb activity. Taken together, phosphorylation of Rb protein is 
important for cell cycle checkpoint at different phases. 
Rb was the first identified tumor suppressor gene. Rb protein family members include Rb, 
p130, and p107 genes (66). However, Rb is the only most frequent mutated or deleted gene 
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in different types of human cancers (48, 67). The functions of Rb are to sequester E2F family 
of transcription factors and other proteins associated with apoptosis, DNA damage 
response, differentiation, protein kinases, hormone regulation, and so on (68-72). 
Inactivation of Rb can be approached by optimal phosphorylation on the Rb protein, or by 
viral oncoproteins such as E7 protein of human papilloma virus, adenovirus E1A and SV40 
large T-antigen that can occupy the pocket domain of Rb (48, 60, 73). The extracellular 
growth factors can bind to the surface receptors and activate ras/raf/mitogenic activated 
protein kinase (MAPK) cascade, which promote G1 phase progression by activate cyclin D-
CDK4/6 and cyclinE/A-CDK2 activity. Phosphorylation of Rb by these CDKs not only 
releases E2F transcription factor but also remodels the chromatin structures by escaping 
from the repressive functions mediated by histone deacetylation complex (HDAC) and 
BRG1/BRM ATPase, the human homolog of yeast SWI2/SNF2 chromatin remodeling 
factors (60, 74-76). Mutation or over-expression of surface receptors may over-activate 
intracellular Ras or myc pathway that constitutively inactivates Rb for accelerating the G1/S 
phase progression and leads to tumorigenesis (77). Alternatively, mutation or inactivation of 
CDK inhibitors may also lead to excessive inactivation of Rb even the mitogenic signaling 
pathway is normally regulated. The role of CDK inhibitors on regulation of cell cycle and Rb 
activity is discussed next.  
4. Regulation of cyclin/CDK on Rb inactivation by CDK inhibitors 
The kinase activities of cyclin D-CDK4/6 and cyclin E-CDK2 are required for cells to 
progress through the G1 phase. Regulation of CDK activity is dependent on the amount of 
CDK inhibitors (CKIs) in cells. While the basal level of CKI is required for the formation of 
cyclin/CDK complex and the maintenance of its activity, a high level of CKI tends to inhibit 
cyclin/CDK activity (78-81). The physical interactions between CKI and cyclin/CDK is 
required to stabilize or inhibit the activities of CDKs.  
Two families of CKIs have been discovered for controlling the activity of cyclin/CDK. One 
of the families is INK4, which is named for its ability of an inhibition of CDK4 activity. 
Members of this family are p16INK4a, p15INK4b, p18INK4c, and p19INK4d and they specifically 
bind to CDK4,or CDK6, but not other CDKs. Members of CIP/KIP family containing 
broader spectrum inhibition of CDK2 and CDK4/6. This family includes p21CIP1, p27KIP1, 
and p57kip2, and they can bind to both cyclins and CDKs (2). Although each member of the 
CKI families can inhibit CDK activity individually, they may also work cooperatively to 
regulate the G1/S phase progression. For instance, recent reports have suggested that 
CIP/KIP protein bound on CDK4 are released and re-bound to CDK2 by introducing INK4, 
which replaces the CIP/KIP and binds to CDK4 to cause G1 phase arrest (82-84).  
Given that both classes of CDK inhibitors are essential for controlling the cell growth and 
DNA replication, deregulation of these molecules usually leads to malignancy. Loss of INK4 
gene functions has been detected in a variety of human cancers via deletion, mutation or 
silencing of the chromosomal 9p21 locus (85). An INK4-CDK4/6-Rb regulatory pathway is 
considered essential for promoting apoptosis and senescence in cells insulted by oncogenic 
stimuli such as ras (86). INK4 can activate Rb and sequester E2F transcriptional factor for 
DNA replication, so loss of INK4 leads to Rb inactivation and carcinogenesis caused by ras 
over-expression. On the other hand, the CIP/KIP family members are rarely mutated or 
deleted in human cancers. Instead, their expressions in various cancer cells are reduced 
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through mis-regulated post-translational stability, reduced transcription, or even microRNA 
(3). Although CIP/KIP family proteins are regarded as tumor suppressors because of their 
cell cycle regulatory role, the subcellular localizations of these proteins may alter their tumor 
preventive role to completely opposite functions. For example, increased cytoplasmic 
p27KIP1 level has been found in tumors with higher grade, strong metastatic capacity and 
poor prognosis, such as breast, cervical, esophagus, uterus cancers, and 
leukemia/lymphoma (87-90). Also, over-expressed or mislocalized p21CIP1 in cytoplasm is 
found in advanced and poor prognostic cancers including glioblastoma, carcinomas of 
prostate, pancreas, breast, cervix, and ovary (3, 91, 92). The underlying mechanisms are not 
understood, however, it has been reported that the tumor-promoting functions of CIP/KIP 
family proteins is likely to be associated with actin cytoskeletal organization and cancer 
motility (90). The RhoA signaling pathway is influenced by the cytoplasmic CIP/KIP family 
proteins to reorganize actin networks in cell motility. The detailed mechanisms will be 
described below. In addition, relocalization of CIP/KIP family proteins from the nucleus to 
cytoplasm may inactivate Rb by over-activated CDKs, further explain the tumor-prone 
manner of such a misregulation (90, 93).  
Up-regulation of CIP/KIP proteins is usually detected in cells that are insulted by 
extracellular stimulation, such as inhibition of cell adhesion, addition or removal of 
mitogens, and ionizing radiation. However, the molecular mechanisms responsible for 
accumulation of p21CIP1 and p27KIP1 are not identical. Gene transactivation is the primary 
pathway for up-regulation of p21CIP1. Many transcriptional responsive elements on the 
p21CIP1 promoter are capable of regulating gene expression in response to different 
stimulations (94). For example, Sp1 sites on the p21CIP1 gene promoter can respond to 
phorbol ester (PMA), histone deacetylase inhibitors (TSA), or TGF-for gene 
transcription. Also, cytokines IL-6 and IFN-can transactivate the p21CIP1 gene through 
STAT1 binding sites. In addition, ionizing radiation is able to activate wild-type p53 to 
transactivate the p21CIP1 gene through the p53 consensus binding sites on the p21CIP1 
promoter (95). In response to ionizing radiation, cells with wild-type p53 up-regulates 
p21CIP1 to induce G1 phase arrest (96-98). In contrast to p21CIP1, regulation of p27KIP1 level 
is dependent on posttranslational control (99). Phosphorylation of p27KIP1 on Thr-187 is 
dependent on cyclin E/CDK2 and is essential for protein degradation through the 
ubiquitin-proteasomal mechanism (100, 101). It has been reported that SCFSkp2 ubiquitin 
ligase complex, which is composed of four major subunits (Skp1, Cul1, Rbx1/Roc1, and F-
box protein Skp2), is responsible for degradation of phosphorylated p27KIP1 (102). 
Inhibition of Thr-187 phosphorylation or Skp2 results in an inhibition of the entry into S 
phase. Also, another phosphorylation site on p27KIP1 (Ser-10) was reported. In contrast to 
Thr-187, Ser-10 phosphorylation can increase the stability of p27KIP1 protein in quiescent 
cells by promoting nuclear export of p27KIP1 through CRM1/exportin1 (103-106). It can 
mediate the cytoplasmic relocalization of p27KIP1 and promote cellular migration induced 
by hepatocyte growth factor (107). In addition to ser-10 phosphorylation, cytoplasmic 
localization of p27KIP1 can be induced by phosphorylation of Thr-157 and Thr-198 
mediated by Akt/PKB or p90 ribosomal S6-kinase (p90RSK) for certain biological functions 
that require further investigations (89, 108, 109). Collectively, it appears that regulation of 
p27KIP1 and p21CIP1 is mediated by different pathways. Regulation of CDK activity for Rb 
function in different phases of cell cycle by cyclins, CKIs and other proteins is 
summarized in Table 1 (Table 1).  
www.intechopen.com
 
Cytoskeletal Organization and Rb Tumor Suppressor Gene 
 
139 
Phase Cell cycle regulators Molecular functions b 
Rb activation/ 
inactivation 
G0 
INK4 (p15INK4a, p16 INK4b, 
p18 INK4c,p19 INK4d) 
Bind to and inactivate CDK4/6  activation 
 p27kip1 
Binds to and inactivates cyclinD-CDK4 
complex 
activation 
 cyclin C Binds to and activates CDK3  inactivation 
 cyclin D1 Binds to and activates CDK4/6  inactivation 
G1 cyclin D2 Binds to and activates CDK4 inactivation 
 cyclin E 
Binds to and activates CDK2, can degrade 
p27 
inactivation 
 CIP/KIP (p21
cip1, p27kip1, 
p57kip2) a 
Bind to and inactivate cyclin D-CDK4 or 
cyclin E-CDK2 complex 
activation 
S cyclin A Binds to and activates CDK2 inactivation 
 cyclin D3 Binds to and activates CDK4 inactivation 
G2 cyclin A Binds to and activates CDK2 inactivation 
 cyclin B1 Binds to and activates CDK1 inactivation 
 p21cip1 Inhibits CDK1 activity when DNA damage activation 
 Rb/histone H1 kinase Phosphorylates the N-terminal of Rb undetermined 
Prophase MPF Promotes cyclin B1 synthesis inactivation 
 cyclin B1 Binds to and activates CDK1 inactivation 
 MAPK Phosphorylates Rb in Xenopus oocytes inactivation 
 cdc25 Activates CDK1 by dephosphorylation inactivation 
Metaphase MAD2 Inhibits cyclin B1 degradation inactivation 
 BubR1 Mad2-interacting proteins for cyclin B1 
degradation 
activation 
Anaphase APC Promotes cyclin B1 degradation activation 
Telophase cdc14 
Activates APC-cdh2 to promote cyclin B1 
degradation 
activation 
a. Functions on CDK inhibition may only occur when CIP/KIP binds to cyclin/CDK with more than 1:1 
stoichiometry  
b. These functions are primarily included but may not be limited.  
Table 1. Molecules involved in regulating CDK mediated Rb activation or inactivation 
The cell cycle checkpoint is required to ensure the integrity of the genome during cell cycle 
progression. The function of the checkpoint is to prevent aberrant DNA from replication or 
chromosomal segregation. One of the most important regulators for the G1/S checkpoint is 
p53 (110, 111). Under normal physiological conditions, the protein level of p53 is controlled 
by a specific negative regulator called MDM2, which binds and promotes the degradation of 
the p53 protein. The activity of MDM2 can be inhibited by p19ARF tumor suppressor, which 
is a target gene transactivated by E2F transcriptional factor (112, 113). Because release of E2F 
is controlled by Rb inactivation, the orchestration among the tumor suppressors and potent 
proto-oncogenes is important for preserving the functions of checkpoint. In response to 
DNA damage, p53 is phosphorylated and dissociated from MDM2. The p53 protein is 
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subsequently resistant to degradation and accumulated in the cells (114). Accumulated p53 
enters the nuclei and transactivates the downstream gene p21CIP1 for G1 phase arrest. In the 
absence of p53, p21CIP1 is not up-regulated and G1 phase arrest is abrogated after DNA 
damage. The molecular regulation of G1/S phase progression, including a variety of CDKs, 
CKIs, Rb, and p53, is illustrated in Figure 3. 
 
Lee YJ et al. 
Fig. 3. Molecular regulation of cell cycle progression from G1 to S phase. CDK 
phosphorylates Rb to release E2F transcription factor for S phase entry and progression. The 
activity of cyclin/CDK is stimulated by growth factors and is regulated by CDK inhibitors, 
including p21cip1/p27kip1 and INK4 family. p53 mediates the expression of p21CIP1 to induce 
G1 phase arrest, but not p27KIP1 or INK4 family. INK4 may cooperate with p27KIP1 to induce 
efficient G1 phase arrest under specific stimulation. 
In adhesive cultures, cell attachment is required for entry into the cell cycle. Cells can only 
be stimulated by growth factor or mitogenic signals after they are anchored onto 
substratum. Given that actin cytoskeleton is involved in cell attachment and spreading, 
organization of actin structures may be important for cell cycle progression. The detailed 
molecular regulation through actin cytoskeletal organization and related biological events 
are discussed in next section.  
5. Actin cytoskeleton in regulation of G1 phase progression and Rb activity 
Following cytokinesis, cells enter G1 phase by the presence of growth factors that stimulate 
a series of signal transduction in cytosol through the surface receptors. The growth factor (or 
serum)-dependent cell growth includes several events: attachment onto extracellular matrix, 
spreading, and locomotion. These anchorage-dependent and morphology-dependent effects 
are important for G1 phase progression and S phase transition. Actin cytoskeletal 
organization is stimulated by growth factors and is involved in the mechanical and 
structural mediated cell cycle progression and growth (13, 115, 116). Also, the time interval 
of G1 phase is usually long and can be divided into early, mid, and late G1 phase in 
proliferating cells. The essence of actin cytoskeleton for G1 phase progression, however, is 
dependent on the stage of G1 phase. For instance, accumulated literatures have shown that 
intact actin cytoskeleton was required for mid to late G1 phase progression (116-120). Also, 
serum stimulation and cell anchorage may also be involved in the G1 phase progression 
(121). Essentially, the actin cytoskeletal organization affects Rb activity in G1 phase 
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progression via different signaling pathways. We will elucidate the association between 
actin networks and Rb mediated G1 phase progression according to the literatures reviewed 
so far.  
The organization of actin filaments is believed to be important for initiation of cell growth 
after cell attachment. Actin inhibitors are routinely adopted for disrupting the actin 
cytoskeleton in vitro and in vivo. The perturbation of cell cycle was subsequently analyzed 
by different approaches. The levels of G1 phase arrest were determined from DNA content 
measured by Feulgen or propidium iodide (PI) staining, or by 5-bromo-2´-deoxyuridine 
(BrdU) labeling for S phase entry after drug treatment. The significance of actin filaments is 
to convey the extracellular signals and form an appropriate shape for G1 phase progression 
(13). It is reasonable that disruption of actin filaments would lead to a G1 phase arrest. 
Indeed, exposure of cultured cells to sublethal concentration of actin inhibitors, such as 
cytochalasin or latrunculin, cause actin cytoskeletal destabilization and G1 phase arrest (117-
119, 122). In some cases, cells were synchronized to G1 phase using lovastatin (118) or 
serum-starvation (117) before cytochalasin treatment to avoid the interference of results 
from cells in other phases of cell cycle. Progression of G1 cells into subsequent phases of the 
cell cycle was monitored after adding back mevalonate, serum or epidermal growth factor 
(EGF). Based on these studies, it is concluded that intact actin cytoskeleton is required for 
responding to extracellular stimuli after the mid-G1 phase (118). Disruption of actin 
cytoskeleton affects cells in passing the "restriction (R)" point for S phase entry (117, 120). 
Also, once cells enter S phase, the phosphorylation of Rb and CKI p27KIP1 are not influenced 
by cytochalasin D treatment (118). Therefore, preservation of sufficient mechanical force for 
attachment and spreading by actin cytoskeleton on the solid substratum, is critical for G1 to 
S phase transition in anchorage-dependent cells.  
The cytoskeleton formed by actin filaments is an important component for cellular 
adherence and cell shapes. Actin filaments are primarily concentrated beneath the plasma 
membrane for the formation of cortical actin cytoskeleton and actin bundles. Cell anchorage 
and shape formation are associated with cytoskeletal tension, and they are able to induce 
cyclin D1 gene transcription for inactivating Rb and promoting G1 phase progression (13, 
120, 123, 124). The cyclin E/CDK2 activity in late G1 phase and S phase entry is also 
influenced by cell adhesion. In contrast to cyclin D1, the cyclin E and CDK2 levels do not 
change significantly following cell adhesion and actin cytoskeletal formation. It is likely due 
to reduced expression of p21CIP1 and p27KIP1 that can bind to and inhibit cyclinE/CDK2 
complex, although other mechanisms are also involved (5, 123, 125, 126). Both cyclin D1 and 
cyclin E associated CDKs activity can inactivate Rb and p107 for S phase entry upon cell 
adhesion. Cyclin A, another important molecule responsible for S phase progression, can 
bind to CDK2 and replace the position occupied by cyclin E. Cell adhesion also promote 
cyclin A expression through E2F4-dependent or -independent mechanisms (115, 127). E2F4 
is another member of E2F transcriptional factor family, and it is important for cyclin A gene 
transactivation (128). The E2F4-independent transactivation of cyclin A gene for S phase 
progression is possibly due to c-myc and CAATT binding proteins after cells attach and 
spread on the substratum (129, 130). Molecular regulations of cell adhesion and cell shape 
changes in G1 phase progression can be blocked by actin inhibitors that induce 
destabilization of actin cytoskeleton. The effects of actin cytoskeletal destabilization on cell 
cycle progression are usually consistent with the results of cells cultured in suspension or 
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cell spreading is limited by microfabricated substrates containing fibronectin-coated 
adhesive islands (116, 121, 124). 
Intact actin cytoskeleton is important for Rb inactivation by releasing the E2F transcriptional 
factor for promoting DNA replication. However, the pathways that mediate actin inhibitors 
induced actin cytoskeletal destabilization are diverse. For instance, Huang and Ingber 
proposed that cytochalasin D causes down-regulation of cyclin D1 and up-regulation of 
p27KIP1 (118). Reshetnikova et al. found that dihydrocytochalasin B inhibited the expression 
of cyclin E but not cyclin D1 in Swiss 3T3 cells (117). However, the levels of p21CIP1 and 
p27KIP1 were not affected under the same treatment. Fasshauer et al. suggested that 
disorganization of actin filaments using latrunculin A, latrunculin B, or cytochalasin D leads 
to reduction of c-jun and cyclin (D1, E, A) expression and inhibition of entry into S phase 
(131). Interestingly, Rb and p107 double-null mouse embryo fibroblasts (MEFs) are able to 
reach mid-G1 phase without serum stimulation, whereas they can not transit to the S phase 
without anchorage (121). This observation is based on a comparison of the expression of 
cyclin E in Rb-/-p107-/- cells between normal attachment and suspension cultured 
conditions. Growth factor stimulation, cytoskeletal organization and cell anchorage are 
essential for cyclin D1 induction and Rb phosphorylation until mid-G1 phase (121, 132, 133). 
Disruption of actin cytoskeleton leads to dephosphorylation and activation of Rb in wild-
type cells but not in RB pocket proteins-null cells. In agreement, a TKO MEF with deletions 
of all Rb pocket proteins exhibits impaired G1 phase arrest and aneuploidy following 
disruption of actin cytoskeleton (134). In addition, Rho small GTPase protein mediated 
signaling pathway is involved in actin stress fiber formation, p27KIP1 degradation and cyclin 
D1 expression, which promotes Rb inactivation as well as cyclin E/CDK2 activation for 
entry of the G1 phase (132, 133, 135). Together, although the molecular events for actin 
cytoskeletal regulated G1 phase progression may be different among cell types, Rb family 
protein can be regarded as a common checkpoint molecule that allows cells with intact actin 
cytoskeleton passing through the G1 to S phase (Figure 4). 
Several lines of evidence have shown that actin cytoskeleton may be important for 
cytoplasmic localization of tumor suppressor p53 during the cell cycle progression (136-138). 
Sequestration of p53 in the cytoplasmic portion is important for prevention of cell cycle 
arrest and apoptosis under normal cell growth (139). Activation of p53 by cytochalasin D 
was also reported, while this effect is associated with drug induced apoptosis (140). In 
addition, cytochalasin B can induce DNA fragmentation in specific cell types (141). On the 
other hand, disruption of actin cytoskeleton induced G1 phase arrest has been reported to be 
associated with Rb pocket protein rather than p53 activation (134). We also demonstrated 
that actin inhibitors induced a p53-independent up-regulation of p21CIP1 in various 
mammalian p53-null cancer cell lines (142). Up-regulated p21CIP1 is dependent on a post-
translational pathway to increase the protein stability and activate Rb for the G1 phase 
arrest. The response of p27KIP1 is relatively weak under the same condition of treatment. 
Taken together, it appears that different drugs used for disruption of actin filaments can 
activate different pathways to cause G1 phase arrest. Induction of p53-independent G1 
phase arrest by actin inhibitors is especially interesting because p53 tumor suppressor is 
frequently inactivated or mutated in human cancers. The Rb tumor suppressor may play an 
important role in mediating the actin cytoskeletal destabilization that causes G1 phase 
arrest. It is also of interest to further investigate the crosstalk between p21CIP1 and Rb 
regarding toxins-induced actin cytoskeletal destabilization.  
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Fig. 4. Growth factor stimulated Rb inactivation is mediated by the actin cytoskeletal 
integrity. Intact actin cytoskeleton organized by the Rho signaling pathway leads to a 
repression of CIP/KIP family proteins and increase of G1 phase associated cyclin/CDKs 
activity, which can inactivate Rb by serine/threonine phosphorylation (P). Activated Rb 
may increase p27KIP1 stability through a down-regulation of Skp2 gene (see text). Whether 
inactivated Rb can oppositely inhibit CIP/KIP proteins remains an opening question.  
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To avoid unexpected side-effects raised by actin toxins, use of actin regulatory proteins for 
molecular-based destabilization of actin cytoskeleton should be an interesting approach to 
investigate the cell cycle effect. Since the formation of actin filaments is regulated by actin-
binding proteins, forced expression of the related proteins may be able to destabilize actin 
filaments and influence the cell cycle distribution. Indeed, over-expression of gelsolin, an 
actin-regulatory protein, has been reported to activate the G2 checkpoint in human cancer 
cells by gene transfection (143). Over-expression of G-actin sequestrating protein thymosin 
4 also caused S and G2/M phase arrest in human colon cancers (144). Moreover, over-
expression of profilin-1, an actin polymerizing molecule, induces G1 phase arrest in MDA-
MB-231 breast cancer cell line through p27KIP1 stabilization (145). In our lab, we focused on 
actin dynamic regulator cofilin-1 and showed that induction of cofilin-1 expression in 
human lung cancer cells led to a G1 phase arrest via p27KIP1 regulatory pathways (39, 40). 
Also, Rb phosphorylation is apparently reduced by forced expression of cofilin-1. Although 
destabilization of actin cytoskeleton by different actin regulatory proteins may inhibit cell 
cycle progression through distinct routes, it is obvious that actin cytoskeleton is important 
for cancer cells and would be an important target for therapeutic design.  
6. Rb, actin cytoskeleton, and cancer 
Rb is a tumor suppressor gene, which is usually loss-of-function in a broad spectrum of 
human cancers (146, 147). The actin cytoskeletal organization induced cyclin D1 expression 
and CDK activity is essential for Rb phosphorylation. Destabilization of actin cytoskeleton 
activates Rb by dephosphorylation of the protein, whereas loss of Rb may abrogate G1 
phase arrest and lead to aneuploidy for rapid cell death (134). Therefore, it seems plausible 
that actin inhibitors are ideal for the treatment of Rb-deficient cancers. Several different 
classes of actin inhibitors, such as cytochalasin and latrunculin, have been subjected to the 
clinical chemotherapy trial (148, 149). Because Rb is not mutated in normal tissues, these 
actin inhibitors may exhibit selective activities between the cancer mass and surrounding 
tissues. Moreover, we have recently found that latrunculin can increase the radiosensitivity 
in human lung cancer cell lines (unpublished data). Although the underlying mechanisms 
remain to be addressed, we expect that latrunculin can be used as a radiosensitizer for 
cancer treatment. In fact, we have shown that over-expression of cofilin-1 can destabilize 
actin architectures and increase the cellular radiosensitivity by suppressing the DNA repair 
capacity (150). Up-regulation of cofilin-1 was also found in cells exposed to latrunculin 
(unpublished data), suggesting that actin inhibitor can suppress cytoskeletal dynamics and 
DNA damage responses consequently.  
Phosphorylation of Rb is mainly dependent on G1 cyclin associated CDKs, which is also 
controlled by CKIs. The CIP/KIP family proteins are found to be up-regulated by actin 
inhibitors. The stabilities rather than mRNA levels of these proteins are usually increased 
after destabilization of actin cytoskeleton or by limiting the cell anchorage and spreading. It 
has been reported that p27KIP1 coordinates with CDK and Rb to control the proliferation and 
migration in vascular smooth muscle cells and fibroblasts (151). Interestingly, recent studies 
propose that Rb can reversely influence the p27KIP1 expression through inhibition of Skp2, a 
pivotal molecule required for p27KIP1 degradation (4, 152). Analysis of the promoter of Skp2 
gene showed that an E2F binding site was essential for gene transcription (4). Therefore, it 
becomes clear that p27KIP1 level should be ablated by Rb-E2F during G1/S phase transition 
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depending on the cyclin E/CDK2 activity. Activation of Rb is sufficient to suppress Skp2 
expression and increase p27KIP1 stability. Therefore, it is speculated that disruption of actin 
cytoskeleton can also trigger the Rb-Skp2-p27KIP1 auto-regulatory circuit and inhibit G1/S 
phase transition. Skp2 has been found to be over-expressed in several cancers (153, 154). 
Targeting on Skp2 has been reported to suppress the tumorigenesis (155). Whether use of 
actin inhibitors can also repress Skp2 expression would be an interesting direction for 
investigation. In Rb-deficiency cancer cells, disruption of actin cytoskeleton may overlook 
the checkpoint by excessive suppression of p27KIP1 expression for apoptosis (134). Over-
expressed Skp2, although it may promote tumorigenesis, may become a reversed knife to 
induce death of cancer lacking Rb expression following disruption of actin architectures.  
Metastasis is the primary cause of cancer mortality, and Rho-mediated actin reorganization 
is believed to be essential for enhanced cancer cell motility. The CIP/KIP family proteins 
have been reported to regulate molecules of Rho signaling pathway when they are 
relocalized to the cytoplasm from the nucleus (3). For instance, p27KIP1 can bind to Rho small 
GTPase (93), p21CIP1 binds to Rho kinase (ROCK) (156) and p57kip2 binds to LIMK for actin 
reorganization (157). All of these events may increase cell motility by activating cofilin-1 for 
promoting the actin dynamics at the leading edges. Also, lack of nuclear CIP/KIP proteins 
may concomitantly inactivate Rb and enhance cell cycle progression. Whether disruption of 
actin cytoskeleton can affect cytoplasmic CIP/KIP and subsequently reactivate Rb is of 
interest to be further investigated. It is speculated that reactivation of Rb by nuclear 
relocalization of CIP/KIP proteins in cancer cells can be achieved by treatment with actin 
inhibitors.  
7. Conclusion and perspectives 
More than five thousand of research publications have been dedicated to Rb and 
tumorigenesis in the passed two decades. As the first identified tumor suppressor gene, it is 
no doubt that Rb is an important target for designing new cancer therapeutic agents. Studies 
of actin cytoskeletal organization in cell anchorage and spreading have greatly improved the 
understanding of the relationship between growth factors mediated cell cycle progression 
and Rb inactivation. Since disruption of actin cytoskeleton is known to activate Rb and block 
G1 phase progression, the actin inhibitors may prevent cancer growth. Especially, activated 
Rb can repress Skp2 oncogene and increase the stability of p27KIP1, which is a consequence of 
actin cytoskeletal disruption. Also, actin inhibitors may promote aneuploidy and death in 
Rb-deficient cancer cells. Although targeting on actin cytoskeleton and consequent Rb-
related pathways provides a promising future in cancer treatment, several critical problems 
remain to be noticed and addressed: (1) It is not clear whether actin inhibitors can efficiently 
distinguish the malignancy from normal tissues? What is the optimal dose for cancer 
prevention with minimum damage to normal tissues? (2) Will actin inhibitors induce 
genomic instability and mutation in malignancy, especially for those that lack Rb 
expression? (3) Since actin inhibitors not only block G1 phase progression but also G2/M 
and cytokinesis, it is unclear whether Rb is also involved in the checkpoints of different 
phases of the cell cycle after actin inhibitor treatment? (4) It is of interest to know whether 
actin inhibitors can affect the expression or activity of actin-binding proteins on the cell cycle 
perturbation. Do actin inhibitors affect Rb activity through signaling pathways that 
regulates specific actin-binding proteins? (5) Does altered expression of actin-binding 
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proteins influence Rb activity? If yes, what are the potential molecular mechanisms? These 
questions are involved but not limited to the further exploration of the interactions between 
actin cytoskeletal organization and Rb biology. It is believed that a comprehensive study of 
actin skeleton and Rb, and related pathways and mechanisms will broaden the view of Rb 
biology on cancer treatment.  
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